Company took measures to protect employees from H1N1 flu: National poll

NewsGuard 100/100 Score

In response to the H1N1 flu, most employees at U.S. businesses say their company took measures to protect them from illness, such as encouraging sick employees to stay home, according to a national poll of employees by researchers from the Harvard Opinion Research Program at Harvard School of Public Health (HSPH). Smaller, but notable, percentages of employees reported that their company took other actions such as creating back-up systems for employees to cover each others' work and expanding leave policies.

The poll was conducted April 21 to May 13, 2010 among a nationally representative sample of 1,491 employees from private sector businesses outside of education and health who employ 20 or more persons.

"These results suggest that in a future contagious disease outbreak, many businesses will try to adapt their policies to mitigate the impact on employees, with most adopting protective precautions, such as encouraging sick workers to stay home, and a minority taking other important measures, such as expanding sick leave policies," said Robert J. Blendon, Professor of Health Policy and Political Analysis at HSPH and director of the Harvard Opinion Research Program (HORP).

Concerning responses recommended by public health officials, most employees (81%) reported that their companies provided hand sanitizer, alcohol-based hand rub or hand-washing stations to reduce the spread of H1N1 at the workplace. A similar percentage (80%) said their companies encouraged employees to stay home from work if they were sick with flu-like symptoms.

Some 60% of employees reported that their company encouraged them to get the H1N1 vaccine. According to employees' reports, large companies, those with 500 or more employees, were more likely than medium (100 to 499 employees) or smaller (20 to 99 employees) companies to do this (66% v. 54% and 48%, respectively).

"Businesses can be a vital public health partner with health authorities during an outbreak," said Gillian K. Steelfisher, Research Scientist in the HSPH Department of Health Policy and Management and a member of the polling team. "Public health officials at federal, state and local levels should develop plans that specifically bring educational materials and preventive measures into the workplace."

A majority of employees, 77%, said their company provided them with information about how to keep H1N1 flu from spreading between employees at the workplace. Again, large companies were more likely than medium-sized companies (100 to 499 employees) or smaller companies (20 to 99 employees) to have provided this information (83% v. 72% and 65%, respectively).

More than a third of employees reported that their company provided them with information about changes to leave policies that would make it easier for them to stay home from work because they were sick (42%), because a family member was sick (38%), or because their children's school closed (36%). Similar percentages of employees reported that their company created a back-up system for someone to cover their work if they got sick (42%) or trained them to cover for someone else if they got sick or had to be absent due to H1N1 (36%).

Most employees (81%) reported that their company was prepared for the H1N1 outbreak (44% "very prepared," 37% "somewhat prepared"). Employees at large companies, with 500 or more employees, were more likely than employees at small companies, those with 20 to 99 employees, to say this (85% v. 73%).

Half of all employees (50%) say that this outbreak of H1N1 has made their company more prepared for a possible future outbreak of a serious, contagious illness.

About one in five (21%) employees got the H1N1 vaccine, mirroring rates in the general population. However, vaccination rates were significantly higher among employees whose companies encouraged them to get the vaccine than among employees whose companies did not do this (29% v. 9%).

A prior survey from HORP looked at business preparedness for H1N1:

"Four-Fifths of Businesses Foresee Severe Problems Maintaining Operations If Significant H1N1 Flu Outbreak," September 9, 2009

Others polls of the public concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program (HORP) at HSPH are listed below:

"Nearly Half of Americans Believe H1N1 Outbreak is Over, Poll Finds," February 5, 2010

"Poll Finds Three Quarters of Parents Who Tried to Get H1N1 Vaccine for Their Children Have Gotten It," December 22, 2009

"Poll: Travelers Taking Significantly More Precautions Against H1N1 and Seasonal Flu on Trips This Year," December 10, 2009

"Poll Finds Two-thirds of Parents and High-priority Adults Who Tried to Get H1N1 Vaccine Were Unable to Get It," November 6, 2009.

"Survey Finds Just 40% of Adults Absolutely Certain They Will Get H1N1 Vaccine," October 2, 2009

"National Survey Finds Six in Ten Americans Believe Serious Outbreak of Influenza A (H1N1) Likely in Fall/Winter," July 15, 2009

"Survey Finds Many Americans Have Taken Steps to Protect Themselves Against H1N1," May 8, 2009

"Survey Finds Nearly Half of Americans Concerned They Or Their Family May Get Sick from Swine Flu," May 1, 2009.

Source: Harvard School of Public Health

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows potential for universal flu vaccine with broad antibody response